Shigeyoshi Harada 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（13 件）

• [2024] Late-Stage Derivatization of Oleanolic Acid-Based Anti-HIV-1 Compounds
  DOI: https://doi.org/10.1248/cpb.c23-00891
• [2024] Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults
  DOI: https://doi.org/10.1056/evidoa2300290
• [2023] Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication
  DOI: https://doi.org/10.1016/j.bbrc.2023.04.046
• [2022] Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors
  DOI: https://doi.org/10.1016/j.bmc.2022.117083
• [2022] Development of a novel Macaque-Tropic HIV-1 adapted to cynomolgus macaques
  DOI: https://doi.org/10.1099/jgv.0.001790
• [2022] Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection
  DOI: https://doi.org/10.1097/qad.0000000000003323
• [2022] Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds
  DOI: https://doi.org/10.1016/j.bmcl.2022.128768
• [2022] Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses
  DOI: https://doi.org/10.1016/j.xcrm.2022.100520
• [2022] Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors
  DOI: https://doi.org/10.1016/j.bmc.2022.116616
• [2022] Hybrids of Small CD4 Mimics and Gp41-Related Peptides as Dual-Target HIV Entry Inhibitors
  DOI: https://doi.org/10.2139/ssrn.4239700

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。